NVO gains as foundation unveils EUR 60M cardiometabolic research push
- Posted on June 23, 2026
- By Bing News
- 0 Views
- 1 min read
NVO gains as foundation unveils EUR 60M cardiometabolic research push
Novo Nordisk NVO shares gained 6.2% on Monday after the Novo Nordisk Foundation, the controlling shareholder of the Danish drugmaker, unveiled a major pan-European initiative to accelerate drug discovery and the development of next-generation therapies for cardiometabolic diseases (CMDs). The initiative aims to advance innovation in areas such as obesity, type II diabetes (T2D) and cardiovascular disease, which remain central to Novo Nordisk’s...
